Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -697 | -832 | -618 | -455 |
| Depreciation Amortization | 28 | 23 | 19 | 12 |
| Accounts receivable | -10 | -30 | N/A | N/A |
| Other Working Capital | 200 | 85 | 41 | 25 |
| Other Operating Activity | 437 | 719 | 527 | 399 |
| Operating Cash Flow | $-42 | $-35 | $-31 | $-19 |
| Cash Flows From Investing Activities | ||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 50 | 50 | 50 | 25 |
| Financing Cash Flow | $50 | $50 | $50 | $25 |
| Beginning Cash Position | 4 | 4 | 4 | 4 |
| End Cash Position | 11 | 19 | 23 | 9 |
| Net Cash Flow | $8 | $15 | $19 | $6 |
| Free Cash Flow | ||||
| Operating Cash Flow | -42 | -35 | -31 | -19 |
| Free Cash Flow | -42 | -35 | -31 | -19 |